CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-02 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −324 | $57.68 | $19K | 19,539 |
| 2024-12-02 | Robb Gary Charles Chief Business Officer | Grant or award | +290 | $59.21 | $17K | 19,829 |
| 2024-12-02 | Robb Gary Charles Chief Business Officer | Grant or award | +290 | 20,119 | ||
| 2024-12-02 | Lyon Joseph Douglas See Remarks | Shares withheld for taxes | −165 | $57.68 | $10K | 8,329 |
| 2024-12-02 | Lyon Joseph Douglas See Remarks | Grant or award | +215 | $59.21 | $13K | 8,544 |
| 2024-12-02 | Lyon Joseph Douglas See Remarks | Grant or award | +215 | 8,759 | ||
| 2024-12-02 | Mokari Atabak Chief Financial Officer | Shares withheld for taxes | −182 | $57.68 | $10K | 12,336 |
| 2024-12-02 | Mokari Atabak Chief Financial Officer | Grant or award | +231 | $59.21 | $14K | 12,567 |
| 2024-12-02 | Mokari Atabak Chief Financial Officer | Grant or award | +231 | 12,798 | ||
| 2024-11-22 | Robb Gary Charles Chief Business Officer | Sale | −2,609 | $56.20 | $147K | 20,163 |
| 2024-11-22 | Robb Gary Charles Chief Business Officer | Gift | −300 | 19,863 | ||
| 2024-11-22 | Lyon Joseph Douglas See Remarks | Sale | −1,411 | $56.72 | $80K | 8,494 |
| 2024-11-11 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $12.13 | $27K | 2,200 |
| 2024-11-11 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $59.88 | $132K | 0 |
| 2024-11-11 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 12,800 | ||
| 2024-11-04 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +3,394 | $21.65 | $73K | 9,190 |
| 2024-11-04 | Guyer William Chief Development Officer | Sale 10b5-1 | −3,394 | $48.97 | $166K | 5,796 |
| 2024-11-04 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −3,394 | 450,000 | ||
| 2024-11-01 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +6,606 | $21.65 | $143K | 12,402 |
| 2024-11-01 | Guyer William Chief Development Officer | Sale 10b5-1 | −6,606 | $48.97 | $323K | 5,796 |
Page 34 of 61 · 1,220 trades